Introduction
Drug-eluting stents (DES) have dramatically reduced restenosis in comparison with bare-metal stents (BMS) in coronary artery disease. 1) However, stent thrombosis has emerged as a major safety concern after DES implantation. Pathological studies have shown that delayed arterial healing characterized by poor endothelialization and accelerated neoatherosclerosis induced by hypersensitivity reaction to polymer and chronic inflammation, and they possibly increase the risk of late or very late DES thrombosis. 2) Intravascular imaging techniques, such as intravascular ultrasound, optical coherence tomography, and angioscopy, enable assessment of inadequate vascular response after DES implantation and help to understand pathogenesis of DES thrombosis.
Several clinical studies have shown comparative outcomes of paclitaxel-eluting stent (PES), Zilver PTX and baremetal stent (BMS), Zilver implanted into the superficial femoral artery. However, detailed process of vascular healing after implantation of the 2 different stents is little known. We assessed a total of 3 patients of successfully deployed 1 BMS and 2 PES who underwent angiographic and angioscopic follow-ups after 6 months of the intervention. The degree of neointimal stent coverage (NSC) was classified into presence of uncovered struts (grade 0), visible struts through a thin neointima (grade 1), or invisible struts with complete neointimal coverage (grade 2). Also, the existence of in-stent thrombus was also evaluated qualitatively using angioscopy. In a case of BMS, follow-up angiography confirmed stent patency. Angioscopy showed that stent struts were fully and homogeneously covered by proliferating white neointima (grade 2) without thrombus. One PES was angiographically patent but another showed diffuse restenosis. In a case without restenosis, angioscopy showed heterogeneous neointimal coverage within the PES segment. Although stent struts were clearly visible and neointimal coverage was absent (grade 0) at the proximal site, thick neointima covered stent and the struts were invisible (grade 2) at the mid and distal segments without thrombus. In a case of restenosis, angioscopy found thin and thick neointima (grade 1 and 2, respectively) as heterogeneous artery healing of the PES with no thrombus. This angioscopic observation revealed that heterogeneous growth of neointima in Zilver PTX, while Zilver showed homogenous healing at 6 months of their implantation.
Key words: arterial healing, angioscopy, bare-metal stents, drug-eluting stents, peripheral artery disease months after EVT confirmed patency of the Zilver. Angioscopy (Vecmova NEO; FiberTech, Tokyo, Japan) showed that stent struts were fully covered by proliferating neointima without thrombus (Fig. 1) .
Case Presentation

Two cases of DES
A 62-year-old woman visited our hospital due to left leg pain at rest and ulcer in the hallax. her left side of ABI was 0.68. Angiography showed total occlusion in the left SFA and she underwent EVT after loading DAPT, aspirin 100mg/day and clopidogrel 75mg/day. Through a contralateral approach from the right CFA with a 6-Fr guiding sheath (Destination) and following intra-arterial unfractionated heparin, the severe stenosis was crossed with a 0.014-inch guide wire (Treasure XS TM ; Asahi Intec Co., Hanoi, Vietnam) under the support of a microcatheter (CX-I TM ; COOK Japan Co., America). Zilver PTX (7.0 mm × 120 mm) was then implanted after balloon angioplasty (X-TREME TM 3.0 mm × 120 mm; Japan Medtronic Co., Italy). Additional balloon angioplasty (X-TREME, 7.0 mm × 80 mm) was performed for post-dilatation. Final angiogram showed good results. Her ABI of the left leg improved to 1.17 and symptom completely disappeared. Follow-up angiography at 6 months indicated patency of Zilver PTX. Angioscopy showed heterogenous neointimal coverage in the stent segment. At the in-stent proximal site, stent struts were clearly visible and neointimal coverage was not seen. By contrast, thick neointima completely covered stent and the struts were invisible at the mid and distal segments of the stent (Fig. 2) .
The second case is a 71-year-old man presented with claudication corresponded to thick neointima on angioscopy (Fig. 3) .
Discussion
We demonstrated angioscopically vascular healing response of Zilver and Zilver PTX in the SFA. Heterogeneity of neointimal growth was observed in Zilver PTX, whereas Zilver showed homogenous healing at 6 months of their implantation.
Zilver, peripheral BMS, is a self-expanding stent, while available coronary stents including BMS are balloon-expandable. Vascular healing response after stenting cannot be concluded by angioscopic observation in a few cases, because not only stent type but also patient characteristics operate on that. However, partially delayed neointimal coverage and heterogeneous healing of Zilver PTX was more remarkable than those of Zilver.
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